Oda K, Hayashi H, Yamamoto K, Kondo S, Katanoda T, Okamoto S, Miyakawa T, Iwanaga E, Nosaka K, Kawaguchi T, Nakata H.

Antibiotic spectrum coverage scoring as a potential metric for evaluating the antimicrobial stewardship team activity: a single-center study.

https://pubmed.ncbi.nlm.nih.gov/39387201/

Endo S, Nishimura N, Toyoda K, Komohara Y, Carreras J, Yuki H, Shichijo T, Ueno S, Ueno N, Hirata S, Kawano Y, Nosaka K, Miyaoka M, Nakamura N, Sato A, Ando K, Mitsuya H, Akashi K, Tenen DG, Yasunaga JI, Matsuoka M, Okuno Y, Tatetsu H.

Decreased PU.1 expression in mature B cells induces lymphomagenesis.

Maruyama D, Jacobsen E, Porcu P, Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, Feldman T, Imaizumi Y, Izutsu K, Morishima S, Yamauchi N, Yuda J, Brammer JE, Kawamata T, Ruan J, Nosaka K, Utsunomiya A, Wang J, Zain J, Kakurai Y, Yamauchi H, Hizukuri Y, Biserna N, Tachibana M, Inoue A, Horwitz SM.

Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.

Yamada A, Yasunaga JI, Liang L, Zhang W, Sunagawa J, Nakaoka S, Iwami S, Kogure Y, Ito Y, Kataoka K, Nakagawa M, Iwanaga M, Utsunomiya A, Koh K, Watanabe T, Nosaka K, Matsuoka M.

Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.

https://pubmed.ncbi.nlm.nih.gov/37950425/

Morikawa K, Izumiya Y, Takashio S, Kawano Y, Oguni T, Kuyama, N, Oike F, Yamamoto M, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Matsuzawa Y, Usuku H, Yamamoto E, Ueda M, Tsujita K.

Early experience with daratumumab-containing regimens in patients with light-chain cardiac amyloidosis.

https://pubmed.ncbi.nlm.nih.gov/39577830/

Usuku H, Yamamoto E, Sueta D, Shinriki R, Oike F, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Takashio S, Kawano Y, Oda S, Kawano H, Ueda M, Tsujita K.

A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis.

Kawano N, Ikezoe T, Seki Y, Yamakawa K, Okamoto K, Fukatsu M, Madoiwa S, Uchiyama T, Asakura H, Yamada S, Koga S, Ishikura H, Ito T, Iba T, Uchiba M, Kawasaki K, Gando S, Kushimoto S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Mayumi T, Wada H; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis.

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancy.

https://pubmed.ncbi.nlm.nih.gov/39674834/

Nakamura T, Uchiba M, Nakata H, Mizumoto T, Beppu T, Matsushita S.

Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report.

Yamamoto T, Furukawa A, Zhou Y, Kono N, Kitajima S, Ohguchi H, Kawano Y, Ito S, Araki N, Ohtsuki S, Masuda T.

Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cells.

https://pubmed.ncbi.nlm.nih.gov/39687025/

Shichijo T, Yasunaga JI, Sato K, Nosaka K, Toyoda K, Watanabe M, Zhang W, Koyanagi Y, Murphy EL, Bruhn RL, Koh K, Akari H, Ikeda T, Harris RS, Green PL, Matsuoka M.

Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.

Utsunomiya A, Yasunaga JI, Tabuchi T, Nakano N, Odawara J, Kubota A, Tokunaga M, Miyazono T, Matsuoka M, Ito Y, Tashiro Y.

A 25-year clonal resurrection in adult T-cell leukemia-lymphoma relapse.

https://pubmed.ncbi.nlm.nih.gov/39719504/

Nakamura T, Tatetsu H, Higuchi Y, Endo S, Shiraishi S, Kawanaka K, Imakane D, Sonoda M, Furuta R, Shichijo T, Honda Y, Karube K, Mikami Y, Nosaka K, Matsuoka M, Yasunaga JI.

Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.

https://pubmed.ncbi.nlm.nih.gov/38538318/

Yamakawa K, Okamoto K, Seki Y, Ikezoe T, Ito T, Iba T, Gando S, Ushio N, Totoki T, Wada T, Asakura H, Ishikura H, Uchiba M, Uchiyama T, Kawasaki K, Kawano N, Kushimoto S, Koga S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Madoiwa S, Mayumi T, Yamada S, Wada H; Committee of the Clinical Practice Guidelines for Management of Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis.

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis.

Iriyama N, Iwanaga E. Kimura Y, Watanabe N, Ishikawa M, Nakayama H, Sato E, Takayuki T, Mitsumori T, Takaku T, Nakazato T, Tokuhira M, Fujita H, Ando M, Hatta Y, Kawaguchi T.

Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.

Kaneko K, Suto M, Miyagawa E, Mikami M, Nakamura Y, Murashima A, Takehara K.

Preconception underweight impact on postnatal osteoporotic fracture: a retrospective cohort study using Japanese claims data.

BMC Pregnancy Childbirth 25;24(1):315,2024.doi: 10.1186/s12884-024-06514-y.

https://pubmed.ncbi.nlm.nih.gov/38664710/

Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Murotani K, Shimizu M, Matsuda A, Ozawa K, Nakao S.

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: Follow-up of a phase II/III study.

Kawano Y, Nishimura N, Yasunaga JI.

Serum monoclonal immunoglobulin light chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis.

Usuku H, Yamamoto E, Sakata K, Hirata S, Toda A, Oike F, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Sueta D, Kanazawa H, Arima Y, Takashio S, Matsuzawa Y, Kawano H, Yasunaga JI, Tsujita K.

Usefulness of platelet count to predict concomitant valvular heart disease in patients with systemic lupus erythematosus.

https://pubmed.ncbi.nlm.nih.gov/38826833/

Nakamura T, Yoshinouchi T, Okumura M, Yokoyama T, Mori D, Nakata H, Yasunaga JI, Tanaka Y.

Diverse antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitro.

Kusumoto S, Munakata W, Machida R, Terauchi T, Onaya H, Oguchi M, Iida S, Nosaka K, Suzuki Y, Harada Y, Miyazaki K, Maruta M, Fukuhara N, Toubai T, Kubota N, Ohmachi K, Saito T, Rai S, Mizuno I, Fukuhara S, Takeuchi M, Tateishi U, Maruyama D, Tsukasaki K, Nagai H.

Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305).

https://pubmed.ncbi.nlm.nih.gov/39034771/

Izutsu K, Ando K, Nishikori M, Shibayama H, Goto H, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Abe M, Hojo S, Nakanishi T, Rai S.

Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study.

https://pubmed.ncbi.nlm.nih.gov/39179948/

Oda K, Okamoto S, Iwanaga E, Nakata H.

Investigating the WHO’s AWaRe classification for assessing antimicrobial stewardship programs: A single-center study.

https://pubmed.ncbi.nlm.nih.gov/39233122/